Publikation

Phase II explorative trial to prospectively investigate predictive molecular biomarkers for efficacy of panitumumab (P) in platinum-pretreated head and neck squamous cell cancer (HNSCC)

Konferenzpapier/Poster - 29.09.2015

Siano Marco